Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Overview of attention for article published in Frontiers in immunology, March 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 208 X posts from 166 X users, with an upper bound of 587,138 followers.

God Bless those who take Paxlovid on an extended basis. Might be fucked. Oh, well.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 204 additional X posts.